explore -WSS

explore

author：explore 2025-09-28 18:59:17 - browse：24413

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： STAT letters to the editor on burnt

Wikipedia

WSS

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

What PEPFAR has meant on the ground in Ukraine

Medicare wants to send $9 billion to 340B hospitals

Roche to buy Carmot Therapeutics, developer of obesity drugs

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Wikipedia

explore

knowledge

Continuity nursing helped my family in our darkest PICU moments

Wisconsin governor employs partial veto to fund schools for 4 centuries

At least 13 dead in Texas as scorching temps continue

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pregnancy discrimination could be enabled by AI

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT letters to the editor on burnt

Hepatitis C has a cure — but many Americans still lack access to it

Patients' immediate access to test results puts radiologists in a bind

focus

Leukemia patients are helped by Syndax's new type of therapy

Pandemic and All Hazards Preparedness Act needs lean update

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

FDA needs staff influx to meet gene therapy needs, Marks says

FDA needs staff influx to meet gene therapy needs, Marks says

STAT letters to the editor on burnt

focus

Wikipedia

hotspot

Wikipedia